NASDAQ:GH | Free Cash Flow | Guardant Health, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2016-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$65.62M$5.58M-$71.2M
2025-12-31-$26.37M$27.85M-$54.22M
2025-03-31-$62.69M$4.46M-$67.15M
2024-12-31-$64.51M$18.88M-$83.39M
2024-03-31-$30.28M$6.93M-$37.22M
2023-12-31-$78.73M$4.08M-$82.81M
2023-03-31-$74.44M$7.52M-$81.97M
2022-12-31-$90.75M$10M-$100.75M
2022-03-31-$28.62M$22.7M-$51.32M
2021-12-31-$76.99M$24.63M-$101.61M
2021-03-31-$16.29M$9.59M-$25.88M
2020-12-31-$59.22M$7.28M-$66.51M
2020-03-31-$13.28M$9.6M-$22.88M
2019-12-31-$30.34M$7.09M-$37.43M
2019-03-31-$4.3M$2.71M-$7.01M
2018-12-31-$26.54M$2.93M-$29.47M
2018-03-31-$6.56M$4.02M-$10.58M
2017-12-31-$17.99M$2.96M-$20.95M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$184.76M$48.31M-$233.07M
2024-12-31-$239.86M$35.09M-$274.94M
2023-12-31-$324.98M$20.49M-$345.46M
2022-12-31-$309.46M$77.46M-$386.92M
2021-12-31-$209.02M$75.04M-$284.05M
2020-12-31-$103.93M$36.17M-$140.1M
2019-12-31-$47.13M$18.72M-$65.85M
2018-12-31-$72.19M$20.2M-$92.39M
2017-12-31-$72.24M$6.68M-$78.92M
2016-12-31-$36.71M$1.77M-$38.48M